Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Weight-loss drugs like Wegovy face coverage cuts, leaving many patients struggling to afford them.
Patients struggle to access popular weight-loss drugs like Wegovy and Zepbound due to inconsistent coverage.
Despite improved supplies, many employers and insurers are reducing coverage, and Medicare does not cover these drugs for obesity.
The high cost, often over $200 per month, makes them unaffordable for many without insurance.
A large portion of the population could benefit from these treatments, but the lack of consistent coverage complicates long-term use and effectiveness.
61 Articles
Medicamentos para bajar de peso como Wegovy enfrentan cortes de cobertura, dejando a muchos pacientes que luchan por pagarlos.